Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3

Apoptosis

Volumn 12, Issue 3, 2007, Pages 525-533

  Martin, Ulrike ^a   Jarasch, Nadine ^a   Nestler, Matthias ^b   Rassmann, Alexander ^c   Munder, Thomas ^c   Seitz, Simone ^a   Zell, Roland ^a   Wutzler, Peter ^a   Henke, Andreas ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

^c HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Apoptosis; Coxsackievirus B3; Cytochrome c; Pan caspase inhibitor; Viral proteases

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; CYTOCHROME C; POLYADENYLIC ACID BINDING PROTEIN; PROTEINASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; EMBRYO; ENZYME RELEASE; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

AMINO ACID CHLOROMETHYL KETONES; CASPASES; CELL LINE; COXSACKIEVIRUS INFECTIONS; CYSTEINE PROTEINASE INHIBITORS; CYTOCHROMES C; ENTEROVIRUS B, HUMAN; HUMANS; VIRAL PROTEINS; VIRUS REPLICATION;

COXSACKIEVIRUS;

EID: 33847271121     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-0015-y     Document Type: Article

References (43)

1. Baboonian C, Davies MJ, Booth JC, McKenna WJ (1997) Coxsackie B viruses and human heart disease. Curr Top Microbiol Immunol 223:31-52
2. Baboonian C, McKenna W (2003) Eradication of viral myocarditis: is there hope? J Am Coll Cardiol 42:473-476
3. Woodruff JF (1980) Viral myocarditis. a review. Am J Pathol 101:425-484
4. Baboonian C, Treasure T (1997) Meta-analysis of the association of enteroviruses with human heart disease. Heart 78:539-543
5. Liu PP, Mason JW (2001) Advances in the understanding of myocarditis. Circulation 104:1076-1082
6. Ramsingh AI (1997) Coxsackieviruses and Pancreatitis. Front Biosci 2:e53-62
7. Pallansch MA (1997) Coxsackievirus B epidemiology and public health concerns. Curr Top Microbiol Immunol 223:13-30
8. Muckelbauer JK, Kremer M, Minor I et al (1995) The structure of coxsackievirus B3 at 3.5 A resolution. Structure 3:653-667
9. Ohlenschlager O, Wohnert J, Bucci E et al (2004) The structure of the stemloop D subdomain of coxsackievirus B3 cloverleaf RNA and its interaction with the proteinase 3C. Structure (Camb) 12:237-248
10. Taylor LA, Carthy CM, Yang D et al (2000) Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays. Circ Res 87:328-334
11. Rassmann A, Henke A, Zobawa M et al (2006) Proteome alterations in human host cells infected with coxsackievirus B3. J Gen Virol 87:2631-2638
12. Huber M, Watson KA, Selinka HC et al (1999) Cleavage of Ras-GAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol 73:3587-3594
13. Luo H, Yanagawa B, Zhang J et al (2002) Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J Virol 76:3365-3373
14. Opavsky MA, Martino T, Rabinovitch M et al (2002) Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus- induced myocarditis. J Clin Invest 109:1561-1569
15. Henke A, Huber S, Stelzner A, Whitton JL (1995) The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69:6720-6728
16. Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL (2003) Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am J Pathol 163:1379-1393
17. Saraste A, Arola A, Vuorinen T et al (2003) Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis. Cardiovasc Pathol 12:255-262
18. Yuan JP, Zhao W, Wang HT et al (2003) Coxsackievirus B3-induced apoptosis and caspase-3. Cell Res 13:203-209
19. Huber SA, Budd RC, Rossner K, Newell MK (1999) Apoptosis in coxsackievirus B3-induced myocarditis and dilated cardiomyopathy. Ann NY Acad Sci 887:181-190
20. Carthy CM, Granville DJ, Watson KA et al (1998) Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol 72:7669-7675
21. Colston JT, Chandrasekar B, Freeman GL (1998) Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis. Cardiovasc Res 38:158-168
22. Carthy CM, Yanagawa B, Luo H et al (2003) Bcl-2 and Bcl-xL overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infection. Virology 313:147-157
23. Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T (2000) Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol 74:4284-4290
24. Henke A, Nestler M, Strunze S et al (2001) The apoptotic capability of coxsackievirus B3 is influenced by the efficient interaction between the capsid protein VP2 and the proapoptotic host protein Siva. Virology 289:15-22
25. Martin U, Nestler M, Munder T, Zell R, Sigusch HH, Henke A (2004) Characterization of coxsackievirus B3-caused apoptosis under in vitro conditions. Med Microbiol Immunol (Berl) 193:133-139
26. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S (1996) A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 70:7811-7818
27. Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL (2002) Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 76:4430-4440
28. Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL (2001) Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol 75:2377-2387
29. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL (2003) Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 8:345-352
30. Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D, Edelstein CL (2002) Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest 110:1083-1091
31. Adrain C, Creagh EM, Martin SJ (2001) Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. Embo J 20:6627-6636
32. Cunningham KA, Chapman NM, Carson SD (2003) Caspase-3 activation and ERK phosphorylation during CVB3 infection of cells: influence of the coxsackievirus and adenovirus receptor and engineered variants. Virus Res 92:179-186
33. Si X, Luo H, Morgan A et al (2005) Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release. J Virol 79:13875-13881
34. Deszcz L, Seipelt J, Vassilieva E, Roetzer A, Kuechler E (2004) Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase. FEBS Lett 560:51-55
35. Barco A, Feduchi E, Carrasco L (2000) Poliovirus protease 3C(pro) kills cells by apoptosis. Virology 266:352-360
36. Calandria C, Irurzun A, Barco A, Carrasco L (2004) Individual expression of poliovirus 2Apro and 3Cpro induces activation of caspase-3 and PARP cleavage in HeLa cells. Virus Res 104:39-49
37. Schotte P, Declercq W, Van Huffel S, Vandenabeele P, Beyaert R (1999) Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett 442:117-121
38. Badorff C, Berkely N, Mehrotra S, Talhouk JW, Rhoads RE, Knowlton KU (2000) Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J Biol Chem 275:11191-11197
39. DeBiasi RL, Robinson BA, Sherry B et al (2004) Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol 78:11040-11050
40. Catalan MP, Esteban J, Subira D, Egido J, Ortiz A (2003) Inhibition of caspases improves bacterial clearance in experimental peritonitis. Perit Dial Int 23:123-126
41. Piguet PF, Kan CD, Vesin C (2002) Thrombocytopenia in an animal model of malaria is associated with an increased caspase-mediated death of thrombocytes. Apoptosis 7:91-98
42. Carlson DL, Willis MS, White DJ, Horton JW, Giroir BP (2005) Tumor necrosis factor-alpha-induced caspase activation mediates endotoxin-related cardiac dysfunction. Crit Care Med 33:1021-1028
43. Piguet PF, Vesin C, Donati Y, Barazzone C (1999) TNF-induced enterocyte apoptosis and detachment in mice: induction of caspases and prevention by a caspase inhibitor, ZVAD-fmk. Lab Invest 79:495-500